April 16, 2020
ADELAIDE, Australia and LIEGE, Belgium, April 16, 2020 /PRNewswire/ -- Mayne Pharma Group Limited (ASX: MYX) and Mithra Pharmaceuticals, SA (Euronext Brussels: MITRA) today announced that Mayne Pharma has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA),...
Source URL: https://www.prnewswire.com:443/news-releases/mayne-pharma-submits-new-drug-application-for-e4drsp-to-the-fda-301041620.html
|
